Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1263
  • 1264
  • 1265
  • …
  • ›
  • »

2026-07-14

Why NioCorp Stock Soared Today

2026-07-14

DLocal Director Sebastian Kanovich Sells 25,700 Shares for $398,350 -- Is the Stock a Sell Too?

2026-07-14

No snow? No problem. Vail Resorts ups investment in experiences

2026-07-14

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

2026-07-14

EQS-News: Aumann announces share buyback with an allotment ratio of approximately 6%

2026-07-14

US official says H200 chip shipments to China have begun; Reuters names ZTE among licensed buyers

2026-07-14

A 11.3% Passive-Income Stock I′d Put My Whole TFSA Contribution Into

2026-07-14

More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026

2026-07-14

Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders

2026-07-14

More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026

2026-07-14

Intercontinental Exchange (ICE) Stock May Have a Favorable 20-Percentage-Point Disconnect

2026-07-14

Honduras Launches Bond Buyback, Looks to Sell New Global Debt

  • «
  • ‹
  • …
  • 1263
  • 1264
  • 1265
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 29/Jul/2026 11:04:27
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies